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LOMA LINDA UNIVERSITY CENTER FOR CHRISTIAN BIOETHICS
This article is drawn from a presentation Dr. Provonsha made to medical students at Loma Linda University.
I have carefully chosen the title of this paper. (Isaac Walton’s The Compleat Angler was obviously in mind as the source of the words.)
The word compleat is an archaic form of the word complete—and that’s a point I wish to make. There isn’t anyone around these days
who is a complete physician—the knowledge explosion of our times has changed all that. One has to reach back into the past even for
the label.
But there are many people who feel a touch of sadness at his passing including quite a few patients—mostly older people who knew
him and a few middle-aged folk who were his patients as children. Some of us around a medical school feel a touch of nostalgia too,
mostly for the idealistic students the old figure inspired. They still come to us once in a while, dreamers who will be brought down out
of the clouds—some with a resounding thud—before we are through with them. Some who formerly had stars in their eyes will be trans-
muted into materialistic cynics by the trauma of it, and that’s a pity. But the majority of students who come to us these days are gener-
ally more or less realistic about medicine, particularly those who come from medical homes. You know that the scientific age has dawned
in medicine, as well as elsewhere, and are ready to face up to the fact. (If you had any illusions they are dispelled by the flood of didac-
tic material with which you are inundated). The burgeoning laboratory facilities, the space-age gadgetry which has become a daily neces-
sity for the practice of good medicine, the increasingly limited amount of time one has available for broad reading, all very quickly orient
today’s student toward specialization and the team approach to practice. If along the way he does happen to run into a compleat physi-
cian, mostly in one- or two-doctor hospitals in primitive mission surroundings, he is likely to be simply appalled rather than inspired.
(Perhaps appalled is not the word, maybe we should say overwhelmed, by what has to be done and how poorly equipped he is to do it.)
The fact is that an increasing number of physicians simply could not practice medicine today at any distance from large city facilities. 
Yes, the compleat physician has almost passed from the scene. In some ways there should be tears shed at his passing. The often
colossal ignorance that he carried in his scruffy black bag is in retrospect not nearly as great a source of reassurance as it was when he
used to carry it in through the door on that dead dodo bird, the house call. How he ever managed to maintain that almost reverential
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else knows more about something than they do, and are willing
to sacrifice something of their own personal prestige for the
good of patients. The complete person does not specialize in
order to achieve status. He does so out of realism, (the knowl-
edge explosion) in terms of his own interests and gifts, and for
the good of patients. Medicine is shot through with incomplete
physicians who are also incomplete persons; there is a frightful
display of envy, competition, status, and economic skulldug-
gery going on in medicine as elsewhere—to it’s shame (and its
generally tarnished public image). “Freedom of enterprise”
is often a catchword for freedom from ethical restraint and con-
trol that has permitted some in medicine to behave like eco-
nomic jackals behind the scenery, and how artfully that scenery
can be placed.
Second, the complete person has a way of looking at other
persons who are the patients. The incomplete physician knows
that his patient is a person who does not have incomplete
needs. It is the physician who specializes, not the patient. He
assumes responsibility for the whole patient in the sense that
where the problem exceeds his own competence he sees to it
that other incomplete physicians become involved, in whose
areas of training the difficulty lies. But as the complete person,
he knows that the patient also has needs that are human rather
than merely technical. The complete physician knows about
and ministers to human needs, be they emotional, social, or
spiritual. These of course may also have their technical require-
ments, and then the incomplete physician calls for assistance
from the appropriate professions or agencies. It is no shirking of
the physician’s task to say what he can to the patient in areas of
the spirit and then to add, “but I have a
friend who can help you more than I in
these matters. May I call him?” But the
complete physician also knows and
understands deeply about such things—it
is a part of his own humanity and personal
walk with God.
Finally, being an incomplete physician
but a complete person says something
about the physician’s consciousness of his
profession—something about the relation
of the part to the whole—not just to the
whole of medicine but the whole of exis-
tence. Herein lies the difference between
a mere technician and one who has a pro-
fession. The technician knows everything
to be known about his own line of work,
except its relation to every other line of
work. If ever there was a time for the
medical profession to resist the forces
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stature he enjoyed is, from this vantage point, difficult to imag-
ine. By present standards he was often but a step from medical
disaster, medically he was far from compleat, yet he was gen-
uinely respected, often even loved, and almost never sued
(though infrequently paid). What has replaced him will never
quite fill his niche in the hearts of grateful patients.
But I am shedding a tear, nonetheless. Not for his lack of
information and meager equipment (though he sometimes
surprisingly compensated for both with his skill as an observer.
There weren’t many of his replacements who could tell as
much about a patient with a stethoscope, looking in a patient’s
mouth, or simply using their nose, as he could). What I am
shedding a tear for is not that the compleat physician is gone,
but that that other thing he was, for which we’ve not found
many replacements, is also in danger of passing with him—he
was also often a complete human being.
Inadequate information can be supplemented, scientific
equipment can be developed and supplied, but it is difficult to
fill the empty shoes of a complete man.
What does it mean to accept the inevitability of practicing
incomplete medicine and yet be a complete person? 
First, it has to do with self image. Specialization—even the
newer possibility of specializing in family medicine (which is
what I engaged in), a considerably more realistic and compe-
tent kind of general practice—requires above all a maturity and
self-acceptance that permits one to trust other people. Only
insecure people have compulsive needs to be omnicompetent.
Emotionally secure physicians can freely admit that someone
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turning physicians into glorified technicians it is now. That
means that it is necessary as never before for the physician to
rediscover his proper place in the larger scheme of things. He
must redefine, as it were, the philosophy of medical practice,
not merely sharpen its technique. What is forced upon us by
the technical explosion is a reexamination of the philosophical,
even metaphysical undergirdings of the task of medicine.
For several centuries medicine has suffered, along with a
number of other aspects of social life, from one of the oldest of
Christianity’s dichotomies, that of a categorical separation
between the sacred and secular.
The gulf between these two areas of life was borrowed from
another—spirit and matter, supernatural and the natural. The
ancients knew a two-story universe in which the upper floor
was reserved for spiritual beings and the lower for material
beings whose proper sphere was nature. The Greeks were the
main source of this separation. The Hebrews and the Bible
knew quite a different scheme of
things. In it there was no radical
disjunction between the super-
natural and natural. God dwelt on
both floors and was active in each.
Thus the incomplete physician
who is a complete person stands
with due humility before the wis-
dom of the body—God’s wisdom.
He knows that God is at work in
every normal physiologic process.
Physicians are sometimes
accused of playing God in the
decisions they are forced to make.
It is true that medical decisions sometimes have enormous con-
sequences for life, death, happiness, or misery, even for the
quality of life to be lived; but the physician who sees God at
work accepts his role with humility born of his incomplete
knowledge, and with the courage derived from awareness that
God may also be at work in his decisions and what a closeness
to God that phrase suggests. It calls to mind a statement by
Ellen G. White. “If we consent, He will so identify Himself
with our thoughts and aims, so blend our hearts and minds into
conformity to His will that when we obey Him we shall be but
carrying out our own impulses” (DA, 668). Being a complete
person while an incomplete physician implies just such close-
ness and dependence on the Great Physician. The complete
person does not fear to make necessary decisions—he only
makes them humbly, with the sense that in being the medium
through which God makes decisions he does not thereby
become God. The God-complex is not an unknown posture of
physicians who are incomplete persons. Some of my medical
colleagues manipulate the bodies of patients who serve their
ego needs. Note well that phrase, for the man who has to play
God has some very deep-seated needs for which he is com-
pensating. Men and women often go into medicine for per-
sonal ego reasons that are unrecognized. Few professions give
as much opportunity for the exercise of personal power. A man,
for example, who enjoys little power at home may find the
pecking order reversed in the operating room and behave like
a tyrant. There is also the occasional opportunity to medically
humiliate persons who would in other circumstances be
socially their superiors. Such physicians play with bodies, even
with personal lives, as if they were objects to be arranged at
will. This is the God-complex as expressed in medicine, even
in the way drugs are used. The complete person who accepts
the fact of his incompleteness in medicine has no such needs,
and enormously respects the body and its processes. All of his
therapeutic actions are designed to assist and cooperate with
the body’s (God’s) own wisdom, not merely to control or
rearrange it with his chemicals
and other agents.
The physician who is sensitive
to God at work is also aware, how-
ever, that nature as now observed
is not only a picture of the divine
activity—there is a snake in the
garden too. He sees the great con-
troversy between good and evil
also expressing itself at the level
of natural process as disease, and
joins the battle against this evil as
one who fights on the side of
God. Whenever such a physician
encounters this evil at work in the body and personality of his
patients he says in effect, “surely an enemy hath done this”
(Matthew 13:28). The physician who cooperates with the
Great Physician is engaged in no casual struggle—but against
the enemies of God. As Jesus Himself pointed out when He
said, “whether is it easier to say thy sins be forgiven thee or to
take up thy bed and walk” (Mark 2:9). There is no semantic
gulf between sickness and sin.
The statement, “In God we live and move and have our
being. Every breath, every throb of the heart, is a continual evi-
dence of the power of an ever-present God,” shows that the
proper posture of the true physician is with head bowed and
shoes placed from off his feet, because this is holy ground. The
physician standing before the human body and its processes is
standing before the handiwork of the most high God. The
anatomist, whether macro or micro, is looking at God’s work-
manship. The physiologist is seeing God in action. It is a mixed
Please turn to page 4
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picture, of course, because of the conflict we just referred to
(and that’s why medical students begin their studies with the
normal, so that they recognize where it departs from the pat-
tern and thus know the enemy when they see him), but nev-
ertheless, insofar as the body operates in it’s normal fashion it
obeys the creative will of God. It is the physician’s task to assist
God in bringing this part of creation back into obedience to its
Creator. This is a holy, sacred task. The true physician will
know that the ancient dichotomy between the sacred and sec-
ular was a perversion of reality, not its true expression; God
dwells on all floors! Insofar as men cooperate with what God is
doing in the world there are no such divisions as sacred and sec-
ular, or sacred and profane professions! There are only sacred
and profane men in them! All of life lived out in harmony with
God, all human activity carried out in obedience to the will of
God, and God’s will involves the whole of creation—nature’s
laws are also God’s laws–is a sacred thing. And what a lot of
human tragedy and ineffectiveness has been traceable to the
failure to recognize that fact. The physician, whether in the lab-
oratory or at the bedside, is doing a sacred work and should
bring to it the sense of reverence and respect that term con-
veys. (Sacred as used here is not synonymous with gloom or
gravity, but with respect.)
A practical consequence of this failure is seen in the image
pre-medical students sometimes have of themselves and their
future professions, even the reasons why they choose medicine
as a career. Even worse is the image others sometimes have of
the profession, and the reason some choose to go elsewhere
than where they belong—in medicine. When I was a student
at Pacific Union College there was an interesting tension
between pre-meds and the pre-ministerial colleagues—includ-
ing administrators. One of my former classmates, a minister,
threw up his hands in horror. “But, Jack, you are a minister!”
Frank apostasy couldn’t have been much worse. Even my
mother could never quite get over introducing her son—who
was now also a doctor—as her minister son, failing to include
the medical aspects of that ministry. During my freshman year
at Loma Linda, Alfred Shryock received a letter from a student
who had been accepted for medicine but then had second
thoughts. Dr. Shryock put the letter on the bulletin board for
us all to read. It stated, in effect, that since he had applied for
admission to the medical school he had been converted and
now decided to go into the ministry, presumably where con-
verted people belong.
That is a false image based on a gross misunderstanding of
God and his work. I suppose what bothers me most is that even
medical people often view themselves and their profession in
this way, and a sacred calling becomes profaned when entered
into by profane people.
The Compleat Physician continued… A true picture of God redemptively at work will enable us to
see that all have ultimately the same call to share with God in
that redemption. The complete person who is also a physician
shares this call with other complete persons, whether they are
ministers, educators, or whatever. But they all share in another
fact; they are all incomplete in their professions. The clergy-
man these days is also an incomplete minister, the educator is
an incomplete teacher, and so on down the line. All have the
same call, but each answers it through the medium of his own
partial profession or work, based on his own peculiar but lim-
ited skills, talents, and opportunities. Only together do we per-
form with God a complete ministry to the needs of humankind.
I repeat, there are no intrinsically sacred and profane pro-
fessions. There are only sacred and profane people in them.
Which brings me to a final important point having to do with
the special function of this school and the Christian physicians
who graduate from it. This has to do with the nature and func-
tion of symbols. Let me take a moment to define my words. A
symbol is an object or action that has a pointing function. It
points beyond itself to another thing or value rather than to
itself. Symbols may be quite arbitrary—such as signs that point
the way to certain places or that bear some kind of necessary
relation to the thing to which they point. A father, (not the
word, but the relation) may be a symbol of God, as Jesus told
us. There is something about the parent-child relation that is
like, and thus belongs to the Divine-human relation. We thus
see in the father-child relationship something about God—it
points to Him and is thus a symbol.
A symbol analogous to the one I wish to consider is the
Sabbath. God set apart a portion of time to point to a certain
quality of all time, and thus in a sense to existence and Himself
as the Creator. The Sabbath as a sacred symbol was to point to
the sacredness of the whole week. It was to call attention to the
fact that the Creator was at work during the week. It was set
apart, because it is the nature of symbols that they must stand
out. They cannot function as symbols unless they are noticed.
Of what value is a sign if nobody can see or read it?
Just as a sacred day symbolically calls attention to the pres-
ence of the Creator in all the days, so the Christian physician is
called to symbolize the sanctity of the healing vocation. There
are no intrinsically sacred or profane professions, but some  serve
as more effective symbols than others. Medicine is one of these
precisely because it is so deeply involved in the human situa-
tion. Within the practice of medicine itself there is need of
physicians who recognize the sacred quality of the profession.
This school and its graduates does and should stand for some-
thing in the world of medicine. That there is a sanctity about
persons, and life, and that God is concerned about the quality of
human existence. In short it should stand for the sacred quality
Please turn to page 5
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of medical practice. It does stand for this, though not always, nor
to the degree that it ought. Some of you may not know how your
school is thought of by people in the world of medicine—even
in the communities and hospitals where its graduates practice.
I’ve watched operating rooms become better places because
Loma Linda surgeons were operating. I’ve seen doctors’ meet-
ings take on a much more wholesome atmosphere because of a
Loma Linda physician’s presence. I’ve seen communities take
on a different character because Christian physicians were influ-
ential in them. And I’ve been proud. But, I’ve also been
ashamed on occasion, and I’d rather not talk about that.
You who are taking your places in the world of medicine are
called to stand for something, and don’t you ever forget it!
Remind yourselves of it daily. The question is, what will you
stand for? Will your life and work point to the sacredness of all
life and work, or will you profane the highest privilege that can
be granted to any human being?
The compleat physician is gone, shed a tear, but also thank
The supply of human donor hearts is very small. According to the United Network for Organ Sharing (www.UNOS.org) there are
approximately 4,100 patients waiting for a human donor heart in the United States at any point in time, yet only approximately 2,200
human hearts are donated each year. While clinically effective, bridging devices such as left ventricular assist systems actually cause the
UNOS waiting list to swell.1 Various educational efforts have been implemented in an attempt to expand the donor pool, yet the allo-
graft shortfall continues. Total artificial heart (TAH) implantation has been attempted in the past; however, technical and ethical com-
plexities abounded.2,3,4 Nonetheless, endeavors to address the ongoing deficit of human donor hearts continue and new designs of total
artificial heart technology are in the early stages of human clinical trials.5,6 Because this technology is beginning to reemerge, clinical
investigators need to be prepared to deal with the ethical complexities of informed consent for these trials. Reflecting on the past and
looking to the future, guidance is offered in preparing informed consent documentation for human clinical trials of artificial replacement
heart technology. 
The shift from animal studies using total artificial heart technology to human clinical trials is not without risk, and it is not enough to
argue that these devices might save lives. While several years’ usage of mechanical cardiac bridging devices has given scientists and clin-
icians much empirical data,7,8 the known and potential risks of a total artificial heart must be carefully weighed in light of the potential
harm to study participants. Thus said, it is critical to emphasize that informed consent is not achieved by the participant’s mere signing
of an “official” form. There are two key components of informed consent: 1) participation must be voluntary, and 2) trial information
(including risks and benefits) must be provided at a level commensurate with the individual’s level of understanding. The autonomy
and welfare of participants, and the integrity of science and medicine as professions rely on both components of informed consent.9
In the United States, Federal law (45 CFR 46.116) regulates informed consent for research studies involving human participants.
The law requires that the informed consent process must include advising participants that the study involves research, as opposed to
standard clinical therapy. The purposes of the research must also be explained, as well as the expected duration of the subject’s partic-
ipation, a description of the procedures to be followed, and identification of which procedures are experimental as opposed to standard
clinical practice. The reasonably foreseeable risks and discomforts (physical, psychological, psychosocial) of study participation must be
Please turn to page 6
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other now as never before. What the world is calling for is the
pooling of the incomplete talents of all of us, in medicine and
beyond.
But what the world needs even more is complete individuals
who, because of the wholeness and integrity of their personal
witness, can become symbols of what God is trying to do in the
world and thus channels of His divine healing. God is in need
of such to dress the world’s wounds so that He can heal them. 
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disclosed, as well as the reasonably expected benefits to the
subjects themselves or to future patients. In the case of TAH
technology, trial participants must be informed if the act of
receiving a TAH will preclude them from receiving an allograft
if the artificial implant fails or other complications ensue.
Participants also need to be informed if they will be permitted
multiple TAH implants in cases of malfunction. 
Many Americans lack health insurance and many more have
only marginal insurance coverage. Because of this, some
patients seek out research studies as a way of accessing thera-
pies at low or no cost.10,11 Some individuals may view a TAH
clinical trial as their “health plan,” if in fact they are unable to
pay for an allograft procedure. Nonetheless, this situation does
not preclude clinical investigators from informing these partic-
ipants that TAH technology is experimental medicine, not a
replacement for standard of practice medicine (allografts) at
this point in time. Individuals lacking health insurance are vul-
nerable to clinical trial recruitment and their objectivity in deci-
sion-making may be impaired; thus it is the responsibility of
the clinical investigator to look out for the subject’s welfare and
best interests. These goals are paramount to study recruitment,
enrollment deadlines, and data collection. 
Federal law requires that appropriate alternative procedures
or courses of treatment, if any, must be disclosed to potential
research participants. Depending on the clinical criteria chosen
for study inclusion, these options may range from medical man-
agement of symptoms to surgical management such as
mechanical assist bridging (with continued waiting on the
UNOS list). For those who are morally opposed to allografts,
medical management of symptoms or a permanent mechanical
assist device would be their only options other than receipt of
a TAH. Also, while the presence of the device’s external bat-
tery pack will likely identify the subject as a TAH recipient,
hospitals must nonetheless inform participants of the proce-
dures that will be used to maintain confidentiality of their per-
sonal clinical information. Patients should be counseled that if
they choose to interact with the media following implantation,
their privacy might be severely affected.
Because total artificial heart technology entails more than
“minimal risk” (defined by the FDA as having the probability
and magnitude of harm or discomfort as not greater than those
ordinarily encountered in daily life or during routine medical or
psychological exams and tests), trial participants must be
informed whether or not any compensation or medical treat-
ments are available if injury occurs and, if so, what they consist
of, and how to obtain further information. The financial
arrangements for both the medical and surgical expenses asso-
ciated with TAH technology should be delineated during the
informed consent process, and subjects should be advised of
the long-term care requirements of their implant. No guaran-
tees (implicit or explicit) should be made about device perfor-
mance. Participants must be informed of whom to contact for
answers to pertinent questions about the research itself and the
rights of research subjects.
Clinical investigators must specify that study enrollment is
voluntary, and that refusal to participate will involve no penalty
or loss of benefits to which the individual is otherwise entitled.
Further, the subject must be informed that he/she may discon-
tinue participation at any time without penalty. This involves
the requirement to instruct participants on the consequences of
device inactivation, as well as the process of device inactivation.
Therapy withdrawal in situations other than futility is ethically
troublesome because there is no ethical consensus as to equat-
ing the concept of withdrawal of TAH therapy with the con-
cept of the subject’s disease state taking its natural course when
in fact the diseased heart is no longer present and the TAH is
functioning normally. Requests to withdraw TAH therapy
should be carefully reflected upon with the aid of a psychiatric
consultation in an effort to determine the status of the subject’s
decision-making capacity as well as the root cause of the sub-
ject’s request to abandon therapy. 
There is no ethical requirement to provide futile therapy.12
In situations of futility TAH therapy can be withdrawn via
device inactivation. While this is ethically permissible, the
potential of a futile outcome should be discussed with poten-
tial research subjects as part of the informed consent process. It
is suggested that the research subject complete an Advance
Directive that would specifically state their treatment prefer-
ences in the event of clinical complications that render the lack
of functional capacity to make decisions. If the research subject
already has an Advance Directive, the subject should review it
to ensure that their stated preferences reflect their values in
light of TAH implantation. Even if a research subject refuses to
complete an Advance Directive, he/she should be required to
appoint two surrogate decision-makers (one primary, one alter-
nate) as part of the informed consent process in the event that
post-surgical complications result in temporary or permanent
loss of decision-making capacity.13 These surrogates (usually
close friends or relatives) will likely know the values of the
research subject and could be able to assist clinicians in deci-
sions about continuation or withdrawal of TAH therapy, as well
as general clinical matters. If these surrogates are unable or
unwilling to function as proxy decision-makers when the time
arises, the hospital should defer to their clinical ethics service or
ethics committee to assume the surrogate role.
In addition to the Federal requirements discussed above,
institutions are not prohibited from requiring their investigators
to make further disclosures to participants. In this age of
Informed Consent Documentation continued…
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biotechnology it is not uncommon for the materials or products
of research to become commercialized. Because of this, institu-
tions should inform research subjects that their tissues or other
biological specimens might be used in a commercial product
such as a cell line.14 Institutions should decide in advance
whether or not subjects will be entitled to financial royalties or
other payments as a result of the use of their specimens, and
this policy should be disclosed to research subjects as part of
the informed consent process.
Conflict of interest, whether actual or perceived, can effect
the integrity of scientific research, as well as science as a pro-
fession. There may be situations in which the individual’s
treating cardiologist may also be an investigator in the artifi-
cial heart clinical trial. In this case, the patient should be
informed of this duality of interest and given the opportunity
to seek a second opinion from a physician who is not associ-
ated with the clinical trial. The patient should be reassured
that they are under no obligation to participate in the trial and
that deciding against trial participation will not adversely
effect the existing doctor-patient relationship. Clinicians
involved in the research study should disclose any potential
conflicts of interest to the institutional review board/human
subjects protection committee of the hospital conducting the
trial, as well as the research subjects.
Informed consent should be documented by the use of a
written consent signed by the research subject. The consent
form must be written in simple, nontechnical language so as to
facilitate comprehension. Novel tools to assist the informed
consent process include videos, question and answer work-
books, photos, sketches, and diagrams. The use of bold face
font, underlined font, and simple paragraph structures can also
aid the effort to calibrate informed consent to a participant’s
level of educational sophistication.15,16 Language that is too
complex or technical might intimidate potential participants to
indicate that they comprehend the information when in fact
they do not. This of course does not imply that simple language
be allowed to dilute the potential risks of the study. It is sug-
gested that subjects be allowed to examine an actual TAH
device and interact with other TAH recipients as part of the
informed consent process. In addition, potential participants
need to be given adequate time to review and contemplate the
study before they actually enroll. This can be accomplished by
requiring a defined time delay between the recruitment inter-
view and the signing of the consent form. 
Participants who cannot give informed consent should be
excluded from TAH clinical trials because these individuals are
very vulnerable. As a patient’s time on the UNOS waiting list
lengthens they experience increasing physical and mental chal-
lenges. Their capacity to comprehend clinical information, as
well as risks and benefits, may become impaired due to physi-
cal and emotional stress. Due to the risk level of experimental
TAH technology, the inability to give informed consent should
preclude trial enrollment. Determination of a patient’s best
interests can be confounded by the fact that there is no way to
determine how long a patient will wait before getting an allo-
graft (if in fact they get one), and patients may feel that a TAH
is their “only hope.” Similarly, if a patient’s cardiac surgery goes
awry, vulnerable family members should not be put in the posi-
tion of trying to make a hasty determination of whether or not
their loved one would want a TAH. Thus, avoiding this ethi-
cally troublesome category of patients is appropriate at this
stage of the technology.
Before proceeding from animal studies to human clinical tri-
als, scientists and clinicians should reflect on the ethical and
technical complexities of TAH technology, including how a
subject’s personal values and vulnerability can impact decision-
making for trial enrollment. Participation should not be the
result of social or financial pressures; rather participants should
understand that the nature of clinical trials, in general, is that
they normally benefit the lives of future patients (as data accu-
mulates and technologies are optimized) and any incidental
benefits to themselves are altruistic bonuses. 
• This article is reprinted with permission from the Japanese
Society for Artificial Organs, (2001) 4:273–277.
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Ralph J. and Carolyn Thompson 
Endowment Established in 2001
The Center for Christian Bioethics was recently pleased to receive notification of another generous financial contribution from
the Ralph J. and Carolyn Thompson Foundation. In 2001, the Thompsons formally established an endowment fund for the
Thompson Library located in the Center for Christian Bioethics. This year the Foundation doubled the principle balance of the
endowment. In addition to building the endowment, the Thompsons donated sufficient funds for the routine needs of the library.
These funds will allow the Center to keep up to date with the rapid expansion in bioethics publications. If you are in the vicinity
of Loma Linda University, you owe it to yourself to come by and experience our library! 
Editor’s note: We apologize to Ralph J. and Carolyn Thompson for the absence of their names on the list of 2001
Contributors in the previous issue of UPDATE (17.3).
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